Henshaw Capital LLC lessened its holdings in Dolby Laboratories (NYSE:DLB – Free Report) by 20.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 34,239 shares of the electronics maker’s stock after selling 8,984 shares during the quarter. Henshaw Capital LLC’s holdings in Dolby Laboratories were worth $2,056,000 at the end of the most recent reporting period.
Other hedge funds have also recently modified their holdings of the company. Teacher Retirement System of Texas boosted its stake in Dolby Laboratories by 19.1% in the 4th quarter. Teacher Retirement System of Texas now owns 115,772 shares of the electronics maker’s stock worth $7,435,000 after purchasing an additional 18,579 shares in the last quarter. Paragon Capital Management Inc. acquired a new position in Dolby Laboratories during the 1st quarter valued at approximately $1,306,000. Hsbc Holdings PLC raised its holdings in shares of Dolby Laboratories by 396.1% in the first quarter. Hsbc Holdings PLC now owns 31,259 shares of the electronics maker’s stock worth $1,875,000 after buying an additional 24,958 shares during the last quarter. Norges Bank purchased a new position in shares of Dolby Laboratories in the fourth quarter worth $54,966,000. Finally, Entropy Technologies LP acquired a new stake in shares of Dolby Laboratories during the first quarter worth $1,674,000. Institutional investors and hedge funds own 58.56% of the company’s stock.
Wall Street Analysts Forecast Growth
DLB has been the topic of a number of research analyst reports. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a report on Wednesday, June 24th. Rosenblatt Securities reaffirmed a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a research report on Friday. Barrington Research reiterated an “outperform” rating and set a $90.00 price target on shares of Dolby Laboratories in a research note on Monday, June 15th. Finally, Wall Street Zen lowered Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Dolby Laboratories currently has a consensus rating of “Moderate Buy” and a consensus target price of $90.75.
Insider Buying and Selling
In other news, CMO Todd Pendleton sold 11,876 shares of the company’s stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $54.55, for a total value of $647,835.80. Following the sale, the chief marketing officer owned 41,480 shares in the company, valued at $2,262,734. This represents a 22.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Robert J. Park sold 4,895 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $56.68, for a total value of $277,448.60. Following the sale, the chief financial officer directly owned 81,490 shares in the company, valued at approximately $4,618,853.20. This trade represents a 5.67% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 47,458 shares of company stock worth $2,639,537. Corporate insiders own 37.93% of the company’s stock.
Key Dolby Laboratories News
Here are the key news stories impacting Dolby Laboratories this week:
- Positive Sentiment: Adjusted earnings beat expectations: Dolby reported fiscal third-quarter adjusted EPS of $0.69, above the $0.67 consensus estimate. Lower operating expenses helped offset weaker revenue. Dolby’s Q3 Earnings Beat Estimates on Lower Operating Expenses
- Positive Sentiment: Upbeat forward outlook: Fiscal fourth-quarter revenue guidance of $362 million to $392 million exceeded the roughly $351 million analyst estimate, while full-year EPS guidance of $4.25 to $4.40 topped the $4.10 consensus. Management cited momentum in video licensing, automotive applications, and new device categories. Dolby Laboratories Reports Third Quarter 2026 Financial Results
- Positive Sentiment: $350 million stock-repurchase authorization: Dolby’s board approved a plan to repurchase up to 7% of outstanding shares, signaling management’s view that the stock may be undervalued and potentially supporting per-share results. Dolby Laboratories Share Repurchase Plan
- Positive Sentiment: Dividend and analyst support: Dolby declared a quarterly dividend of $0.36 per share, representing an approximate 2.5% annualized yield. Rosenblatt Securities reaffirmed its Buy rating and set an $85 price target, well above the recent trading level. Dolby Laboratories Dividend Signals Confidence
- Neutral Sentiment: Cash generation remained strong: Operating cash flow rose to $167.5 million, and Dolby ended the quarter with $669.4 million in cash, providing flexibility for buybacks, dividends, and investment.
- Negative Sentiment: Revenue and reported profitability declined: Third-quarter revenue fell 3.3% year over year to $305 million and missed estimates near $312 million. Reported net income and diluted GAAP EPS also declined from the prior year, reflecting softer device sales and continued pressure in some business areas. Dolby Laboratories Fiscal Q3 Adjusted Earnings, Revenue Fall
Dolby Laboratories Price Performance
DLB stock opened at $58.78 on Friday. The firm’s fifty day simple moving average is $52.29 and its 200-day simple moving average is $58.58. The company has a market capitalization of $5.56 billion, a P/E ratio of 25.01 and a beta of 0.81. Dolby Laboratories has a 12 month low of $48.26 and a 12 month high of $75.80.
Dolby Laboratories (NYSE:DLB – Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The electronics maker reported $0.69 earnings per share for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.06%. The firm had revenue of $305.00 million for the quarter, compared to analyst estimates of $311.96 million. During the same quarter in the prior year, the business earned $0.78 earnings per share. The business’s quarterly revenue was down 3.3% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. As a group, sell-side analysts forecast that Dolby Laboratories will post 3.21 earnings per share for the current year.
Dolby Laboratories Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, August 19th. Shareholders of record on Tuesday, August 11th will be given a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, August 11th. Dolby Laboratories’s dividend payout ratio (DPR) is currently 61.28%.
Dolby Laboratories announced that its Board of Directors has approved a share repurchase program on Thursday, July 30th that permits the company to buyback $350.00 million in outstanding shares. This buyback authorization permits the electronics maker to reacquire up to 7% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s board of directors believes its shares are undervalued.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
See Also
- Five stocks we like better than Dolby Laboratories
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
